Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study).
Nakayama G, Mitsuma A, Sunagawa Y, Ishigure K, Yokoyama H, Matsui T, Nakayama H, Nakata K, Ishiyama A, Asada T, Umeda S, Ezaka K, Hattori N, Takami H, Kobayashi D, Tanaka C, Kanda M, Yamada S, Koike M, Fujiwara M, Fujii T, Murotani K, Ando Y, Kodera Y. Nakayama G, et al. Among authors: ishigure k. Oncologist. 2018 Aug;23(8):919-927. doi: 10.1634/theoncologist.2017-0640. Epub 2018 Jul 26. Oncologist. 2018. PMID: 30049885 Free PMC article. Clinical Trial.
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801).
Nakayama G, Uehara K, Ishigure K, Yokoyama H, Ishiyama A, Eguchi T, Tsuboi K, Ohashi N, Fujii T, Sugimoto H, Koike M, Fujiwara M, Ando Y, Kodera Y. Nakayama G, et al. Among authors: ishigure k. Cancer Chemother Pharmacol. 2012 Oct;70(4):575-81. doi: 10.1007/s00280-012-1948-1. Epub 2012 Aug 12. Cancer Chemother Pharmacol. 2012. PMID: 22886005 Free PMC article. Clinical Trial.
Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial.
Misawa K, Fujiwara M, Ando M, Ito S, Mochizuki Y, Ito Y, Onishi E, Ishigure K, Morioka Y, Takase T, Watanabe T, Yamamura Y, Morita S, Kodera Y. Misawa K, et al. Among authors: ishigure k. Gastric Cancer. 2015 Apr;18(2):417-25. doi: 10.1007/s10120-014-0374-y. Epub 2014 May 7. Gastric Cancer. 2015. PMID: 24801197 Clinical Trial.
Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial.
Fujii T, Nakao A, Murotani K, Okamura Y, Ishigure K, Hatsuno T, Sakai M, Yamada S, Kanda M, Sugimoto H, Nomoto S, Takeda S, Morita S, Kodera Y. Fujii T, et al. Among authors: ishigure k. Ann Surg Oncol. 2015 Nov;22(12):3905-12. doi: 10.1245/s10434-015-4496-1. Epub 2015 Mar 17. Ann Surg Oncol. 2015. PMID: 25777090 Clinical Trial.
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial).
Kotaka M, Yoshino T, Oba K, Shinozaki K, Touyama T, Manaka D, Matsui T, Ishigure K, Hasegawa J, Inoue K, Goto K, Sakamoto J, Saji S, Ohtsu A, Watanabe T. Kotaka M, et al. Among authors: ishigure k. Cancer Chemother Pharmacol. 2015 Jul;76(1):75-84. doi: 10.1007/s00280-015-2757-0. Epub 2015 May 16. Cancer Chemother Pharmacol. 2015. PMID: 25983021 Free PMC article. Clinical Trial.
Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701).
Nakanishi K, Kobayashi D, Mochizuki Y, Ishigure K, Ito S, Kojima H, Ishiyama A, Fujitake S, Shikano T, Morita S, Kodera Y. Nakanishi K, et al. Among authors: ishigure k. Int J Clin Oncol. 2016 Jun;21(3):557-65. doi: 10.1007/s10147-015-0919-z. Epub 2015 Nov 7. Int J Clin Oncol. 2016. PMID: 26547424 Clinical Trial.
80 results